Propel Dr. Cairo's Research to Advance Better Care & Cures
OUR 2025 GOAL IS TO RAISE $150,000 FOR CONTINUED RESEARCH
ABOUT THE CAMPAIGN
For over 40 years the Pediatric Cancer Research Foundation has supported the work of Dr. Mitchell Cairo, who has pioneered important breakthroughs for lymphoma and leukemia patients. Expanding on his successes, Dr. Cairo is now focusing his research on the use of targeted immunotherapy to advance better treatments and outcomes for a variety of cancers, including pediatric ALL, AML, NHL HL, neuroblastoma, Ewing sarcoma, osteogenic sarcoma and gliomas. is approach, which amplifies the body’s own immune system to combat cancer cells, has demonstrated improvements in patient quality of life. However, more progress is needed.
Dr. Cairo says,
"In the last 30 years, there has been a major shift toward increasing the cure rate while also promoting both short-term and long-term quality of life. Patients who receive targeted immunotherapy often experience a better quality of life due to the therapy being precisely directed at the tumor and not at normal tissue or organs."
Your generous contribution will directly support the efforts of Pre-and Post-Doctoral Researchers in Dr Cairo’s lab.